Information
-
Trademark
-
79423293
-
International Classifications
-
Filing Date
March 21, 2025
7 months ago
-
Transaction Date
June 22, 2025
4 months ago
-
Status Date
June 20, 2025
4 months ago
-
Location Date
June 20, 2025
4 months ago
-
Status Code
640
-
Current Location
TMO LAW OFFICE 112
Employee Name
GLUECK, CHRISTOPHER
-
Law Office Assigned Location Code
M30
-
Owners
Mark Drawing Code
4
Mark Identification
SIFTAXYS
Case File Statements
- GS0051: Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases.
- GS0101: Medical and surgical apparatus and instruments; drug delivery devices, including medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set.
Case File Event Statements
-
5/8/2025 - 5 months ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
5/12/2025 - 5 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
5/12/2025 - 5 months ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
6/18/2025 - 4 months ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/21/2025 - 4 months ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
6/20/2025 - 4 months ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT